No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
361 |
4. Check minimum number of eventsNone |
361 |
5. Include endpointsNone |
361 |
6. Filter based on genotype QC (FinnGen only) |
352 |
Control definitions (FinnGen only)
- Control exclude
- M13_ARTHROPATHIES
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M21
- Name in latin
- Inaequalitas hongitudinis membrorum (acquisita)
Similar endpoints
↥List of similar endpoints to
Unequal limb length (acquired)
based on the number of shared cases.
Similar with more cases:
- Other joint disorders
- Arthropathies
- Diseases of the musculoskeletal system and connective tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5169 | 2272 | 2894 |
| Only index persons | 4933 | 2151 | 2782 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.07 | 0.07 | 0.08 |
| Only index persons | 0.09 | 0.08 | 0.11 |
| Median age at first event (years) | |||
| Whole population | 13.10 | 12.57 | 13.51 |
| Only index persons | 13.24 | 12.74 | 13.63 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 352 | 214 | 138 |
| Unadjusted period prevalence (%) | 0.07 | 0.08 | 0.06 |
| Median age at first event (years) | 14.19 | 14.02 | 14.46 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 361
- Matched controls
- 3610
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M21.7
ICD-10 Finland
Unequal limb length (acquired)
+∞
307.7
361
*
NFK20
NOMESCO Finland
Epiphysiodesis of femur
166.4
42.8
44
*
NGK20
NOMESCO Finland
Epiphysiodesis of knee or lower leg
407.2
37.7
37
*
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
370.3
34.5
34
*
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
8.0
31.7
46
65
NF1AA
NOMESCO Finland
Hip X-ray examination
12.0
29.7
31
28
M41.1
ICD-10 Finland
Juvenile idiopathic scoliosis
10.9
28.7
32
32
M25.5
ICD-10 Finland
Pain in joint
3.7
25.7
105
362
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
8.0
24.6
35
48
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
6.8
24.2
40
65
M16.1
ICD-10 Finland
Other primary coxarthrosis
33.7
24.1
31
10
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
19.8
20.8
31
17
N03AX12
ATC
[U] gabapentin; oral
4.5
20.5
56
143
M17.1
ICD-10 Finland
Other primary gonarthrosis
20.3
20.3
30
16
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
7.9
19.8
28
38
NFU20
NOMESCO Finland
Removal of internal fixation device from femur
29.7
19.0
25
9
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
+∞
18.9
18
*
NK6JD
NOMESCO Finland
Ortopaedic measurement of extemities with CT
+∞
17.9
17
*
ZXA00
NOMESCO Finland
Right side
3.4
17.7
76
265
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
94.5
16.7
18
*
N02AX02
ATC
tramadol; systemic, rectal
2.7
15.7
111
509
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
19.4
14.9
22
12
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
83.6
14.7
16
*
M70.6
ICD-10 Finland
Trochanteric bursitis
4.5
14.3
37
90
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
55.6
13.9
16
*
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
4.6
13.9
34
79
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
5.4
12.4
25
49
L13
ICPC
Hip symptom/complaint
3.3
12.4
51
172
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
18.9
12.2
18
10
NJ3NA
NOMESCO Finland
Measurement of difference in extremity lengty with X-ray
123.8
11.5
12
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.3
11.4
46
153
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.5
11.3
87
409
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
13.3
11.3
19
15
M13.9
ICD-10 Finland
Arthritis, unspecified
11.1
10.9
20
19
B01AB05
ATC
enoxaparin; parenteral
2.6
10.6
72
319
Q72.88
ICD-10 Finland
Other reduction defects of lower himb(s)
+∞
10.5
10
*
S82.2
ICD-10 Finland
Fracture of shaft of tibia
10.0
10.4
20
21
ZXA05
NOMESCO Finland
Left side
2.8
10.3
57
227
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
17.3
10.0
15
9
M19.0
ICD-10 Finland
Primary arthrosis of other joints
12.7
10.0
17
14
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
26.9
9.9
13
5
N03AX16
ATC
[U] pregabalin
2.7
9.9
56
226
Z3226
NOMESCO Finland
Physiotherapist
2.6
9.6
63
273
WX320
NOMESCO Finland
Spinalanesthesy
2.6
9.6
59
248
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
12.8
9.4
16
13
SPAT1229
SPAT
Assessment of need for aid
5.1
9.4
20
41
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
+∞
9.4
9
*
NFC20
NOMESCO Finland
Secondary implantation of hip prosthesis
+∞
9.4
9
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
4.0
9.2
27
72
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.8
9.2
21
46
M01AC06
ATC
meloxicam; systemic, rectal
2.4
9.1
73
348
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.1
9.0
113
646
NGU20
NOMESCO Finland
Removal of internal fixation device from knee or lower leg
13.0
8.9
15
12
M79.6
ICD-10 Finland
Pain in limb
2.0
8.8
124
739
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
8.8
108
612
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.6
8.5
55
236
M22.0
ICD-10 Finland
Recurrent dislocation of patella
92.1
8.4
9
*
M41.9
ICD-10 Finland
Scoliosis, unspecified
13.2
8.4
14
11
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
8.4
86
453
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
11.1
8.4
15
14
M21.0
ICD-10 Finland
Valgus deformity, not elsewhere classified
+∞
8.4
8
*
NJ3MA
NOMESCO Finland
Measurement of extremity length with X-ray
+∞
8.4
8
*
M54.4
ICD-10 Finland
Lumbago with sciatica
2.5
8.4
58
258
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.7
8.3
27
78
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
4.5
8.3
20
46
S43.4
ICD-10 Finland
Sprain and strain of shoulder joint
4.7
8.2
19
42
S72.3
ICD-10 Finland
Fracture of shaft of femur
17.7
8.1
12
7
NF1DA
NOMESCO Finland
X-ray of hips
34.2
8.1
10
*
H02AB06
ATC
prednisolone; systemic
2.0
8.0
120
726
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
8.1
8.0
17
22
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.2
8.0
32
106
N02BF01
ATC
gabapentin; oral
3.7
7.8
25
71
L04AX03
ATC
methotrexate; systemic
6.2
7.8
20
34
L01BA01
ATC
methotrexate; systemic
25.6
7.6
10
*
M53.3
ICD-10 Finland
Sacrococcygeal disorders, not elsewhere classified
13.7
7.4
12
9
NGK30
NOMESCO Finland
Angulation, rotation or displacement osteotomy of knee or lower leg
+∞
7.3
7
*
NFK60
NOMESCO Finland
Lengthening osteotomy of femur
+∞
7.3
7
*
NFK50
NOMESCO Finland
Shortening osteotomy of femur
+∞
7.3
7
*
R4110, ,
SPAT
3.4
7.3
27
85
M43.1
ICD-10 Finland
Spondylolisthesis
7.6
7.3
16
22
Z3229
NOMESCO Finland
Other healthcare associate professional
3.1
7.3
30
101
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
4.1
7.3
20
51
SPAT1153
SPAT
Removal of sutures
2.1
7.2
77
411
M01AH05
ATC
etoricoxib; oral
1.8
7.2
156
1059
ZXE00
NOMESCO Finland
One hour or less
1.9
7.1
124
785
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.3
7.0
27
87
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.5
6.9
46
201
NE1AA
NOMESCO Finland
Pelvis X-ray examination
5.9
6.9
18
32
A03FA02
ATC
cisapride; oral, rectal
3.5
6.8
24
73
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.0
6.8
30
105
NFK30
NOMESCO Finland
Angulation, rotation or displacement osteotomy of femur
40.8
6.8
8
*
M01AE03
ATC
ketoprofen; systemic, rectal
2.1
6.7
76
413
N06AA09
ATC
amitriptyline; systemic
3.9
6.7
20
54
A02BC02
ATC
pantoprazole; systemic
1.8
6.6
169
1196
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.2
6.6
63
321
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
6.5
208
1569
M01AB55
ATC
diclofenac, combinations; oral
6.8
6.4
15
23
P01BA02
ATC
hydroxychloroquine; oral
7.2
6.3
14
20
M16.3
ICD-10 Finland
Other dysplastic coxarthrosis
+∞
6.3
6
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
6.3
172
1237
NH3EA
NOMESCO Finland
Feet X-ray examination with load
27.2
6.3
8
*
N02BE01
ATC
paracetamol; systemic, rectal
1.9
6.2
283
2354
L28
ICPC
Limited function/disability (L)
2.5
6.2
39
165
M01AH01
ATC
celecoxib; oral
2.9
6.2
29
105
M54.5
ICD-10 Finland
Low back pain
1.8
6.2
112
712
WX212
NOMESCO Finland
Femoral plexus blockade
12.8
6.1
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
102
552
2.18
9.41
2.0
1.9
—
—
—
0
0
218
1694
1.72
5.86
7.6
5.7
79.24
77.93
u/l
0.15
203
1578
173
1265
1.71
5.79
6.4
5.0
55.31
55.37
%
0.02
164
1197
175
1287
1.70
5.71
6.5
5.1
30.54
30.80
%
0.12
167
1218
55
292
2.04
5.14
1.6
1.7
—
—
—
0
0
159
1169
1.64
5.00
2.8
2.5
—
—
—
0
0
131
920
1.67
4.91
2.9
2.2
74.44
71.67
nmol/l
0.59
121
837
189
1466
1.61
4.69
8.0
8.0
3.77
3.94
e9/l
0.51
168
1259
145
1060
1.61
4.57
5.0
5.7
10.00
10.87
umol/l
0.75
130
992
78
487
1.77
4.44
2.2
2.0
0.65
0.92
mg/l
1.46
61
319
51
279
1.96
4.38
1.3
1.1
12.17
1.39
u/ml
0.54
23
111
122
865
1.62
4.31
6.5
6.0
1.22
1.22
mmol/l
0.15
115
788
53
301
1.89
4.08
1.4
1.1
19.15
12.89
iu/ml
0.46
11
79
93
625
1.66
4.03
2.7
2.5
17.49
40.22
ng/l
1.10
50
301
173
1350
1.54
3.95
4.4
4.4
6.07
6.24
mmol/l
0.47
160
1191
29
134
2.27
3.85
5.3
4.0
1.02
1.57
mmol/l
0.61
20
99
113
806
1.59
3.82
4.6
4.4
37.78
37.54
g/l
0.18
107
756
57
340
1.80
3.76
2.9
3.1
958.65
799.79
ng/l
0.12
44
273
20
79
2.62
3.70
1.8
2.1
—
—
—
0
0
109
777
1.58
3.68
7.3
7.6
1.05
1.12
inr
1.37
39
276
128
957
1.52
3.46
7.4
6.1
1.22
1.22
mmol/l
0.42
110
824
11
28
4.02
3.31
2.8
2.1
18.13
17.95
%
—
6
10
207
1718
1.48
3.30
4.7
2.8
8.62
8.18
mm/h
0.26
191
1571
10
26
3.92
3.00
1.0
1.7
—
—
—
0
0
10
26
3.92
3.00
1.0
1.7
—
—
—
0
0
10
26
3.92
3.00
1.0
1.7
—
—
—
0
0
10
26
3.92
3.00
1.0
1.7
—
—
—
0
0
10
27
3.78
2.90
1.0
1.6
—
—
—
0
0
10
27
3.78
2.90
1.0
1.6
—
—
—
0
0
104
770
1.49
2.87
3.8
2.8
—
—
—
0
0
25
126
2.06
2.73
1.6
1.6
—
—
—
0
0
7
194
0.35
2.62
1.3
2.0
—
—
—
0
0
20
94
2.19
2.60
6.6
4.5
24.45
24.54
mmol/l
0.07
20
94
83
598
1.50
2.59
3.0
2.6
0.12
0.32
e6/l
2.04
61
429
9
25
3.66
2.59
1.3
1.1
—
—
—
0
0
17
75
2.33
2.55
1.7
2.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
10
32
3.18
2.45
7.1
9.5
0.55
0.36
u/ml
—
5
17
11
38
2.95
2.43
3.9
2.9
2.97
3.44
e9/l
0.37
11
38
6
12
5.06
2.41
1.2
1.4
72.83
76.00
umol/l
—
6
12
11
39
2.88
2.36
4.2
3.5
49.00
51.77
%
0.24
11
39
79
577
1.47
2.30
2.2
2.0
2.51
2.60
mg/l
0.19
68
481
232
2039
1.39
2.28
4.2
3.9
37.06
37.35
mmol/mol
0.20
218
1908
7
18
3.94
2.26
1.4
1.4
—
—
—
0
0
32
188
1.77
2.26
2.0
5.5
1.42
1.85
mmol/l
0.50
26
149
33
196
1.75
2.25
4.9
6.0
106.18
104.62
mmol/l
1.27
33
196
13
54
2.46
2.22
2.1
1.4
—
—
—
0
0
50
334
1.58
2.19
2.3
2.4
0.75
0.90
e6/l
0.15
26
171
88
665
1.43
2.14
2.4
3.0
2.38
2.37
mmol/l
0.30
82
599
276
2511
1.42
2.12
5.1
4.2
1.83
1.84
mu/l
0.06
264
2330
32
193
1.72
2.08
1.5
1.5
—
—
—
0
0
40
257
1.63
2.06
7.8
6.2
1.10
1.09
mmol/l
0.07
40
242
6
15
4.05
2.04
1.3
1.9
12.17
10.69
umol/l
—
6
15
261
2359
1.38
2.03
10.7
7.8
99.62
98.08
ml/min/173m2
0.46
219
1793
162
1364
1.34
2.01
2.9
2.5
97.71
75.32
ug/l
0.73
146
1263
86
654
1.41
2.01
3.0
2.2
50.23
58.51
u/l
1.67
79
597
61
435
1.48
2.00
3.6
3.9
3.50
13.13
mg/mmol
2.59
37
301
298
2762
1.45
1.95
13.0
8.8
21.23
21.83
mg/l
0.10
237
1975
27
158
1.77
1.95
4.3
7.4
1.04
1.38
mmol/l
2.24
27
152
16
78
2.10
1.94
1.3
1.6
0.26
0.41
nmol/l
—
9
71
26
151
1.78
1.93
10.3
7.9
5.68
6.39
mmol/l
0.64
26
146
240
2151
1.35
1.90
4.5
3.6
14.58
14.51
pmol/l
0.18
220
1952
0
51
0.00
1.90
0.0
1.2
—
—
—
0
0
11
46
2.44
1.87
1.5
1.5
—
—
—
0
0
56
398
1.48
1.87
3.6
2.6
333.24
6896.35
umol/l
2.00
49
363
22
123
1.84
1.84
5.9
10.6
124.32
127.24
g/l
0.22
22
118
8
29
2.80
1.80
1.0
1.7
—
—
—
0
0
8
29
2.80
1.80
1.4
1.3
—
—
—
0
0
6
18
3.37
1.75
2.5
1.4
—
—
—
0
0
309
2900
1.45
1.73
9.9
6.8
27.94
25.99
u/l
0.71
303
2788
279
2575
1.37
1.71
13.2
9.4
3.91
3.91
mmol/l
0.03
272
2471
148
1253
1.31
1.70
3.9
2.9
0.00
0.00
estimate
-0.00
38
257
50
355
1.47
1.68
1.6
1.6
475.56
22185858.46
pmol/l
0.50
36
302
149
1264
1.30
1.68
4.0
2.9
0.00
0.01
estimate
0.50
38
251
278
2568
1.36
1.67
13.2
9.3
139.36
139.61
mmol/l
0.95
272
2472
40
272
1.53
1.65
1.7
1.6
1079.44
1182.56
nmol/l
0.29
31
206
22
128
1.77
1.64
2.5
2.6
57.29
81.24
ml/min/173m2
—
7
49
147
1250
1.30
1.62
5.1
4.0
0.00
0.00
estimate
-0.00
37
256
35
235
1.54
1.54
3.2
3.0
30.38
32.24
%
0.46
26
174
7
27
2.62
1.52
1.0
1.1
—
—
—
0
0
341
3285
1.69
1.48
18.2
12.8
262.37
257.78
e9/l
0.70
336
3181
341
3287
1.68
1.45
18.0
12.8
40.44
42.16
%
0.62
328
3110
83
662
1.33
1.44
4.2
3.0
0.00
0.01
estimate
0.80
38
252
14
74
1.93
1.41
1.4
5.6
0.66
0.66
%
0.03
14
74
7
29
2.44
1.40
1.4
1.2
—
—
—
0
0
30
200
1.55
1.37
3.8
4.3
234.47
237.75
u/l
0.06
30
194
341
3293
1.64
1.35
18.1
12.7
4.57
4.61
e12/l
0.99
336
3188
29
194
1.54
1.31
1.5
1.6
—
—
—
0
0
5
18
2.80
1.29
1.0
7.1
—
31.60
—
0
5
18
107
1.72
1.28
1.3
1.5
—
—
—
0
0
6
25
2.42
1.25
1.5
1.2
—
—
—
0
0
5
19
2.65
1.22
1.4
1.2
—
—
—
0
0
5
19
2.65
1.22
1.4
1.2
—
—
—
0
0
55
423
1.35
1.21
1.6
1.3
21.49
19.88
nmol/l
0.42
48
364
113
967
1.25
1.12
4.0
2.8
—
—
—
0
0
45
341
1.37
1.10
2.2
2.5
4.41
3.51
e6/l
0.22
22
179
5
106
0.46
1.03
1.2
1.3
—
—
—
0
0
24
166
1.48
0.97
2.6
2.8
0.23
0.23
g/l
0.15
24
154
17
255
0.65
0.94
1.1
1.3
—
—
—
0
0
20
135
1.51
0.91
1.5
1.4
2.34
3.02
mg/l
—
10
82
45
353
1.31
0.90
3.2
3.1
47.25
677.36
ng/l
1.59
33
207
249
2341
1.21
0.88
3.6
3.0
5.63
5.60
mmol/l
0.14
232
2158
23
162
1.45
0.86
6.2
9.9
4.79
5.08
kpa
0.98
23
152
23
162
1.45
0.86
6.2
9.9
14.17
13.92
kpa
0.06
23
153
8
45
1.80
0.85
1.3
1.1
—
—
—
0
0
8
46
1.76
0.83
1.5
1.3
—
—
—
0
0
8
46
1.76
0.83
1.5
1.3
—
—
—
0
0
42
523
0.78
0.79
1.6
2.0
—
—
—
0
0
6
33
1.83
0.79
1.2
1.2
—
—
—
0
0
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
279
2665
1.21
0.77
3.6
3.7
—
—
—
0
0
6
34
1.78
0.76
1.2
2.2
9.80
9.31
g/l
—
6
34
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
5
24
2.10
0.75
1.4
1.2
—
—
—
0
0
14
92
1.54
0.73
1.6
1.3
—
—
—
0
0
257
2442
1.18
0.73
3.6
3.1
4.63
4.61
mmol/l
0.10
246
2311
13
86
1.53
0.67
10.2
7.8
1.08
1.13
mg/l
0.21
13
80
258
2462
1.17
0.65
3.9
3.3
2.81
2.78
mmol/l
0.27
247
2308
13
87
1.51
0.64
1.5
1.6
—
—
—
0
0
5
29
1.73
0.64
1.0
2.4
0.00
0.00
g/l
—
5
29
5
29
1.73
0.64
1.0
2.4
0.00
0.00
g/l
—
5
29
10
152
0.65
0.62
1.3
1.5
—
—
—
0
0
5
30
1.68
0.61
1.0
1.1
207.52
199.04
pmol/l
—
5
30
12
80
1.52
0.60
1.8
1.8
2.29
6.68
iu/l
—
5
24
55
642
0.83
0.60
2.1
2.1
—
—
—
0
0
0
22
0.00
0.59
0.0
1.1
—
0.95
—
0
11
13
89
1.48
0.58
1.7
1.3
240.00
203.64
u/ml
—
5
52
6
35
1.73
0.58
1.2
2.3
2.92
2.76
g/l
—
6
35
8
55
1.46
0.56
1.4
1.6
—
—
—
0
0
63
547
1.18
0.55
1.9
1.6
1.39
1.29
mmol/l
0.38
53
465
253
2424
1.15
0.55
3.5
3.0
1.39
1.45
mmol/l
1.80
243
2288
6
38
1.59
0.54
1.2
2.2
—
—
—
0
0
6
38
1.59
0.54
1.2
2.2
4.85
3.29
g/l
—
6
38
6
38
1.59
0.54
1.2
2.2
7.65
7.09
g/l
—
6
38
52
446
1.19
0.52
2.0
1.7
1.58
1.38
%
0.60
47
406
92
829
1.15
0.51
3.1
2.9
25.39
29.03
u/l
1.55
85
780
241
2311
1.13
0.48
3.2
2.8
1.26
1.17
mmol/l
1.45
233
2176
24
191
1.27
0.48
2.8
2.5
—
—
—
0
0
8
117
0.68
0.46
2.1
2.0
—
—
—
0
0
38
321
1.21
0.46
1.8
2.7
2.42
2.42
mmol/l
0.22
33
286
18
229
0.77
0.44
1.4
1.6
—
—
—
0
0
5
31
1.62
0.43
1.4
1.6
—
—
—
0
0
5
31
1.62
0.43
1.0
2.4
39.32
40.48
g/l
—
5
31
6
93
0.64
0.43
1.5
1.5
—
—
—
0
0
10
139
0.71
0.42
1.1
1.2
—
16.07
—
0
8
5
33
1.52
0.41
1.0
2.3
0.00
0.00
g/l
—
5
33
5
36
1.39
0.38
1.2
1.4
—
—
—
0
0
5
36
1.39
0.38
1.4
1.4
—
—
—
0
0
5
36
1.39
0.38
1.4
1.4
—
—
—
0
0
6
87
0.68
0.33
1.0
1.2
—
—
—
0
0
13
101
1.30
0.32
1.6
1.4
—
—
—
0
0
91
845
1.10
0.32
1.4
1.4
2.06
1.18
u/ml
0.28
31
209
64
583
1.12
0.32
4.0
2.9
1.02
1.02
kg/l
—
10
83
79
730
1.11
0.30
2.0
1.5
99.84
96.19
pmol/l
0.37
39
366
27
232
1.18
0.29
3.7
3.8
24.06
21.38
%
—
10
96
12
94
1.29
0.28
3.4
4.2
3.35
3.26
g/l
0.09
12
89
9
116
0.77
0.28
1.9
2.6
28.89
44.13
u/ml
—
9
109
13
105
1.25
0.25
2.3
2.3
4.96
6.99
ug/l
0.29
13
89
44
482
0.90
0.23
1.5
1.6
—
—
—
0
0
5
39
1.29
0.23
2.2
1.6
—
—
—
0
0
29
258
1.13
0.22
5.2
3.1
5.10
8.16
umol/l
1.05
23
218
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
10.16
—
0
10
0
10
0.00
0.21
0.0
6.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
127.62
—
0
12
0
12
0.00
0.21
0.0
1.0
—
32.93
—
0
12
5
43
1.17
0.21
1.6
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
1.04
—
0
6
0
14
0.00
0.20
0.0
1.6
—
2.48
—
0
14
0
14
0.00
0.20
0.0
2.7
—
22.61
—
0
14
14
165
0.84
0.20
3.0
2.4
0.80
0.69
ug/l
—
8
87
195
1901
1.06
0.18
2.9
2.6
34.62
31.05
u/l
0.43
184
1817
10
121
0.82
0.18
1.2
1.2
—
—
—
0
0
11
91
1.22
0.17
5.2
11.4
23.74
24.70
mmol/l
0.68
11
84
106
1017
1.06
0.17
2.5
2.5
—
—
—
0
0
36
331
1.10
0.17
1.3
1.4
—
—
—
0
0
6
77
0.78
0.15
1.0
1.1
—
—
—
0
0
16
182
0.87
0.15
1.3
1.5
—
—
—
0
0
22
198
1.12
0.14
7.9
4.5
—
—
—
0
0
96
925
1.05
0.13
2.4
2.3
—
—
—
0
0
23
252
0.91
0.13
1.6
1.4
—
—
—
0
0
23
251
0.91
0.12
1.6
1.4
—
—
—
0
0
23
250
0.91
0.11
1.6
1.4
—
—
—
0
0
26
280
0.92
0.11
1.5
1.5
—
—
—
0
0
23
249
0.92
0.10
1.6
1.4
—
—
—
0
0
103
1002
1.04
0.10
1.6
1.7
—
—
—
0
0
12
106
1.14
0.10
1.4
1.5
—
—
—
0
0
19
207
0.91
0.10
1.6
1.7
—
—
—
0
0
23
248
0.92
0.09
1.1
1.0
—
—
—
0
0
5
46
1.09
0.09
1.0
1.3
—
—
—
0
0
5
46
1.09
0.09
1.0
1.3
—
—
—
0
0
62
597
1.05
0.09
1.5
1.5
—
—
—
0
0
30
318
0.94
0.08
1.5
1.4
—
—
—
0
0
6
75
0.80
0.07
1.0
1.1
—
—
—
0
0
8
76
1.05
0.07
1.0
1.1
—
—
—
0
0
9
88
1.02
0.07
1.1
1.4
—
—
—
0
0
30
306
0.98
0.00
2.9
2.5
9408.43
3505.34
u/l
0.31
11
137
23
232
0.99
0.00
2.0
1.8
—
—
—
0
0
26
259
1.00
0.00
1.3
1.3
84.07
137.86
iu/ml
0.87
13
96
13
127
1.02
0.00
1.3
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
8
86
0.93
-0.00
2.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
4.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.4
—
58.74
—
0
5
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
4.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_LIMBLENGTH and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have M13_LIMBLENGTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: M13_LIMBLENGTH – Unequal limb length (acquired)
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data